GFN•TV will bring the conference's platform for rational and inclusive debate on the future role of safer nicotine products and tobacco harm reduction to an audience all year round. GFN•TV will also be broadcasting live from Warsaw in June. Tune in to hear world-leading experts, tobacco harm reduction advocates and nicotine consumers discuss the latest scientific, regulatory and policy developments. From our unique annual event, to year-round reporting of the issues that matter in tobacco harm reduction, GFN has got it covered.
GFN.TV Interviews #49 | DARK SIDE | Tobacco Control’s Penchant for Misinformation
Medical doctor and addictions specialist Garrett McGovern warns that most people in his profession who are anti-vaping seem to want electronic cigarettes to be “more harmful” than they are and it's almost as if “they don't want them to be safe or safer.”
Featuring: DR. GARRETT MCGOVERN Medical Director, Priority Medical Clinic Dublin GP Specialising in Addiction Medicine @AddictionsPMC
📅 24 Sep 2024
A MIXED BAG | Godfrey updates us on the latest events in the THR space
Glimmers of good news despite the general drift towards harsher restrictions for tobacco harm reduction.
📅 20 Sep 2024
Is Impact of Tobacco Harm Reduction Global? | GFN Voices 2024 #6
Our latest GFN Voices features Alex Wodak and Konstantinos Farsalinos, under discussion is the tragic impact of the disinformation campaigns and the role played by organizations like WHO.
📅 17 Sep 2024
DOOMED TO FAIL | Colin Mendelsohn explains Australia's new vape regulations
New legislation in Australia means that vapes can only be bought in pharmacies, with e-liquid only available in three flavours. What are the likely consequences of this, in a country where the black market for vaping products is already booming?
Science is an enabler at Japan Tobacco International, driving innovation in risk-reduced tobacco products and reinforcing its position when responding to critics. 'Each scientific study is a piece of the puzzle,' says Ian Jones, V.P. of the Scientific Product Assessment Center at JTI.
Featuring: IAN JONES V.P., Scientific Product Assessment Center Japan Tobacco International
📅 10 Sep 2024
A South African Perspective on Tobacco Harm Reduction | GFN Voices 2024 #5
In today's GFN Voices episode, Kurt Yeo explore the crucial relationship between economics, health, and tobacco harm reduction. With a focus on South Africa, we delve into the burden tobacco places on public health, the economic challenges it creates, and how harm reduction strategies could be the key to a healthier future.
📅 6 Sep 2024
What's the Truth about Nicotine? | GFN Voices 2024 #4
In this insightful discussion, Liza Katsiashvili, Andrzej Fal and Ethan Nadelmann tackle the growing misconceptions surrounding vaping and tobacco harm reduction. Learn how misinformation, fueled by media and powerful institutions like the WHO, is shaping public opinion and preventing effective harm reduction strategies.
📅 3 Sep 2024
From Oversight to Action: Addressing Smoking Rates in Vulnerable Populations | #GFN24
English subtitles are available through the YouTube 'CC' button!
It is widely recognized that smoking rates among key and vulnerable populations surpass those of other groups. However, across much of the globe, support services often overlook this issue. Consequently, many will face mortality not due to their substance use or mental health conditions, but rather as a result of smoking-related diseases. This session aims to discuss the reasons for this oversight, with a particular emphasis on Eastern Europe and Central Asia, and to generate ideas for effective interventions to address this critical issue.
📅 30 Aug 2024
GFN.TV Interviews | Are Anti-THR Campaigners Guilty of Taking Lives?
Spreading misinformation about nicotine vaping to vulnerable populations leads to dire consequences, warns Kiran Sidhu, a leading THR writer-journalist for Filter.
Harnessing the power of physicians, consumer advocates and regulators to promote THR | #GFN24
In this insightful panel discussion, experts explore the complex relationship between healthcare professionals and users within the context of harm reduction. The panel delves into the challenges of communicating harm reduction strategies to society and policymakers, while addressing the needs and perspectives of both doctors and users.
